Le Lézard
Classified in: Health
Subjects: RCL, PSF

Food Recall Warning - Certain Abbott brand powdered infant formula products recalled due to possible Cronobacter sakazakii and Salmonella


OTTAWA, ON, June 19, 2022 /CNW/ -

Summary
Affected products

Brand

Product

Size

UPC

Codes

Abbott

Similac Advance Step 1 Milk-Based Iron-Fortified Infant Formula Powder

964 g

0 55325 00163 8

L28174SH0

L36099SH0

Abbott

Similac Advance Step 2 Milk-Based Iron-Fortified and Calcium-Enriched Infant Formula Powder

964 g

0 55325 00164 5

L31496SH0

L32642SH0

L29186SH0

Abbott

Similac Alimentum Step 1 Hypoallergenic Infant Formula Powder

400 g

0 55325 00061 7

L35026Z26

Abbott

Similac Advance Step 2 Milk-Based Iron-Fortified and Calcium-Enriched Infant Formula Powder

658 g

0 55325 00077 8

L27887SH0

L31497SH0

Issue

Shoppers Drug Mart is recalling certain Abbott brand powdered infant formula products from the marketplace due to possible Cronobacter sakazakii and Salmonella contamination. The products were previously recalled on February 17, 2022 and some units were sold via on-line in error.

What you should do

Food contaminated with Cronobacter sakazakii may not look or smell spoiled but can still make you sick. Although Cronobacter sakazakii is not commonly linked to human illness, in rare cases it can cause serious or fatal infections. Cronobacter sakazakii can cause rare bloodstream and central nervous system infections and has been associated with severe intestinal infection (necrotizing enterocolitis) and blood poisoning (sepsis), especially in newborns.

Food contaminated with Salmonella may not look or smell spoiled but can still make you sick. Young children, pregnant women, the elderly and people with weakened immune systems may contract serious and sometimes deadly infections. Healthy people may experience short-term symptoms such as fever, headache, vomiting, nausea, abdominal cramps and diarrhea. Long-term complications may include severe arthritis.

Learn more:

Background

This recall was triggered a consumer complaint.

There have been reported illnesses in the United States associated with the consumption of these products. However, there have been no reported illnesses in Canada associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Public enquiries and media

Company information  
Shoppers Drug Mart 
Telephone: 1-866-220-3837 

Public enquiries
Toll-free: 1-800-442-2342 (Canada and U.S.)
Telephone: 1-613-773-2342 (local or international)
Email: [email protected]

Media relations
Telephone: 613-773-6600
Email: [email protected]

                                                             Également disponible en français

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:30
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...

at 07:30
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...

at 07:30
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...

at 07:30
-    AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)-    Data to be presented from...

at 07:28
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire. SOURCE...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...



News published on and distributed by: